5 Important Developments to Follow Next Week

5 important developments to follow next week have been announced. The US emloyment report for July will be among the highlights.

5 important developments that you should know before starting the new week will be as follows.

1. July Employment Report

The US nonfarm emlopyment report on Friday will provide new signals on the strength of the economic recovery and the outlook for Fed politicians. Economists expect the economy to have added 900,000 jobs in July. In June, it exceeded expectations with 850,000.

2. Economic Data

Alongside the jobs report, the economic calendar includes manufacturing data and service sector data from the Supply Management Institute (ISM). The ISM manufacturing PMI data is expected to remain strong, but will again underline the supply-related problems in the economy that contribute to high inflation. Factory orders data will be released on Tuesday, and the first weekly jobless claims report will be released on Thursday. In addition, many Fed officials such as Boston Fed Chairman Eric Rosengren, Fed Vice Chairman Richard Clarida and Fed Administrator Christopher Waller will also speak this week.

3. Earnings Reports

Investors will be looking forward to earnings reports next week from Eli Lilly (NYSE:LLY), CVS Health (NYSE:CVS) and General Motors (NYSE:GM) to name a few.

4. China Stocks

The latest pressure from market regulators in China has scared investors away from Chinese stocks. Accordingly, it has pushed tech companies to operate in an uncertain environment. Next week, investors will be examining China's PMI data as concerns over a recession in the world's second-largest economy rise.

5. BoE Meeting

At its Thursday meeting, the BoE is expected to maintain stimulus at the current pace, despite some disagreements among politicians over the size of its bond-buying program in the face of rising inflation and the emerging economy. Officials may raise their inflation forecast for this year, but the growth outlook remains uncertain amid concerns about the Delta variant.     Source: Investing.com